Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
72 CHF | +0.61% | -0.66% | +9.69% |
03-26 | Alcon Announces Management Changes | CI |
03-26 | Alcon’s Medical Chief to Retire; Successor Named | MT |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- With an expected P/E ratio at 39.54 and 30.45 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- With an enterprise value anticipated at 3.84 times the sales for the current fiscal year, the company turns out to be overvalued.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+9.69% | 38.82B | B | ||
+11.95% | 98.12B | B | ||
-6.10% | 17.66B | B- | ||
-20.02% | 2.24B | D+ | ||
-8.37% | 1.54B | C+ | ||
+29.63% | 1.23B | - | ||
-35.36% | 735M | B- | ||
-35.62% | 747M | - | ||
-13.36% | 623M | - | ||
+24.04% | 494M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- ALC Stock
- Ratings Alcon Inc.